Logo for Orexo

Orexo Investor Relations Material

Latest events

Logo for Orexo

Q1 2024

Orexo
Logo for Orexo

Q1 2024

8 May, 2024
Logo for Orexo

Q4 2023

8 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Orexo

Access all reports
Segment Data
Access more data
Net revenue by
Business area
US Pharma
HQ & Pipeline
Digital Therapeutics
Expenses by
Financials
Orexo AB, a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States. The Company's strategy is to focus on developing products that reduce the risk of opioid dependence, misuse and accidental ingestion by chronic pain patients in need of effective pain management for long-lasting pain, who have been historically underserved. Furthermore, the company is differentiated by their scientifically-validated medications that treat lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The company's mission is to improve the lives of patients through acquisition, development and commercialization of new therapies as quickly as possible, with a focus on digital health technologies to rapidly deliver greater access to leading edge therapies.